| [1] |
苗志敏，赵世华，王颜刚, 等. 山东沿海居民高尿酸血症及痛风的流行病学调查[J]. 中华内分泌代谢杂志, 2006, 22(5):421-425.
|
| [2] |
Dehghan A, van Hoek M, Sijbrands EJ, et al. High serum uric acid as a novel risk factor for type 2 diabetes[J]. Diabetes Care, 2008, 31(2):361-362．
|
| [3] |
Goncalves JP, Oliveira A, Severo M, et al. Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome[J]. Endocrine, 2012, 41(3):450-457．
|
| [4] |
Zhang W, Sun K, Yang Y, et al. Plasma uric acid and hypertension in a Chinese community: prospective study and meta analysis[J]. Clin Chem, 2009, 55(11):2026-2034.
|
| [5] |
中国医师协会心血管内科医师分会，中国医师协会循证医学专业委员会. 无症状高尿酸血症合并心血管疾病诊治建议专家共识[J]. 中国当代医药, 2009, 16(24):1-8.
|
| [6] |
Scire CA, Manara M, Cimmino MA, et al. Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR)[J]. Arthritis Res Ther, 2013, 15(5):R101.
|
| [7] |
Hirsch JD, Terkeltaub R, Khanna D, et al. Gout disease-specific quality of life and the association with gout characteristics[J]. Patient Relat Outcome Meas,2010(2010):1-8.
|
| [8] |
Yoo HG, Lee SI, Chae HJ, et al. Prevalence of insulin resistance and metabolic syndrome in patients with gouty arthritis[J]. Rheumatol Int, 2011, 31(4):485-491.
|
| [9] |
张长青，叶巍，邢晓博, 等. 肥胖与高尿酸血症的关系[J]. 中国分子心脏病学杂志, 2012, 12(5):260-263.
|
| [10] |
朱文华，陈蕾倩，方力争, 等. 高尿酸血症与血脂、肥胖相关因素分析[J]. 浙江预防医学, 2004, 16(12):70-74．
|
| [11] |
冯田田，田福亮，吴晓庆, 等. 血尿酸水平与代谢综合征各组分的相关性研究[J]. 中国糖尿病杂志, 2016, 24(4):317-320.
|
| [12] |
陈光亮，徐叔云. 高尿酸血症研究进展[J]. 中国药理学通报, 2003, 19(10):1088-1092.
|
| [13] |
Ghei M, Mihailescu M, Levinson D. Pathogenesis of hyperuricemia: recent advances[J]. Curr Rheumatol Rep, 2002, 4(3):270-274.
|
| [14] |
张荣欣，景洪江，刘新焕, 等. 不同嘌呤含量饮食对老年高尿酸血症患者血尿酸水平和尿尿酸排泄的影响[J]. 军医进修学院学报, 2008, 29(1):30-32.
|
| [15] |
王淼，赵东，李光伟, 等. 尿酸与胰岛素抵抗关系的人群研究[J]. 中华医学杂志, 2007, 87(46):3260-3263．
|
| [16] |
Baldwin W, McRae S, Marek G, et al. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome[J]. Diabetes, 2011, 60(4):1258-1269.
|
| [17] |
Doshi M, Takiue Y, Saito H, et al. The increased protein level of URAT1 was observed in obesity/metabolic syndrome model mice[J]. Nucleosides Nucleotides Nucleic Acids, 2011, 30(12):1290-1294.
|
| [18] |
Chen CC, Li TC, Li CI, et al. The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women[J]. Metabolism, 2007, 56(9):1216-1220.
|
| [19] |
Bajnok L, Seres I, Varga Z, et al. Relationship of serum resistin level to traits of metabolic syndrome and serum paraoxonase 1 activity in a population with a broad range of body mass index[J]．Exp Clin Endocrinol Diabetes, 2008, 116(10):592-599．
|
| [20] |
Samara A, Herbeth B, Aubert R, et al. Sex-dependent associations of leptin with metablic syndrome-related variables: the Stanislas study[J]. Obesity, 2010, 18(1):196-201．
|
| [21] |
Yoo TW, Sung KC, Shin HS, et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome[J]. Circ J, 2005, 69(8):928-933.
|
| [22] |
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes-3-Year outcomes[J]. N Engl J Med, 2014, 370(21):2002-2013.
|
| [23] |
Ishizaka N, Ishizaka Y, Toda A, et al. Changes in waist circumference and body mass index in relation to changes in serum uric acid in Japanese individuals[J]. J Rheumatol, 2010, 37(2):410-416.
|
| [24] |
Romero-Talamás H, Daigle CR, Aminian A，et al. The effect of bariatric surgery on gout: a comparative study[J]. Surg Obes Relat Dis, 2014, 10(6):1161-1165.
|
| [25] |
Richette P, Poitou C, Manivet P, et al. Weight loss, xanthine oxidase, and serum urate levels: a prospective longitudinal study of obese patients[J]. Arthritis Care Res (Hoboken), 2016, 68(7):1036-1042.
|
| [26] |
Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery[J]. N Engl J Med, 2004, 351(26):2683-2693.
|
| [27] |
Dalbeth N, Chen P, White M，et al. Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes: a prospective longitudinal study[J]. Ann Rheum Dis, 2014, 73(5):797-802.
|
| [28] |
Blüher S, Raschpichler M，Hirsch W, et al. A case report and review of the literature of laparoscopic sleeve gastrectomy in morbidly obese adolescents: beyond metabolic surgery and visceral fat reduction[J]. Metabolism, 2013, 62(6):761-767.
|
| [29] |
Menenakos E, Doulami G, Tzanetakou IP, et al. The use of serum uric acid concentration as an indicator of laparoscopic sleeve gastrectomy success[J]. Int Surg, 2015, 100(1):173-179.
|
| [30] |
Serpa Neto A, Rossi FM, Valle LG，et al. Relation of uric acid with components of metabolic syndrome before and after Roux-en-Y gastric bypass in morbidly obese subjects[J]. Arq Bras Endocrinol Metabol, 2011, 55(1):38-45.
|
| [31] |
Oberbach A, Neuhaus J, Inge T, et al. Bariatric surgery in severely obese adolescents improves major comorbidities including hyperuricemia[J]. Metabolism, 2014, 63(2):242-249.
|